Study of Zanzalintinib (XL092) + AB521 and Zanzalintinib + AB521 + Nivolumab in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Other Advanced Solid Tumors (STELLAR-009)
Clinical trial NCT06191796 · TERMINATED
Trial details
- NCT number
- NCT06191796
- Sponsor
- Exelixis
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-25
- Primary completion
- 2025-05-12
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.